Literature DB >> 16985943

Case scenarios in androgen deficiency.

Andrew McCullough.   

Abstract

Deciding whether to choose androgen replacement for a particular patient is one of the many tasks facing the urologist. Factors including androgen levels, medical history, symptom profile, current medications, and prostate cancer risk all need to be considered when making this decision. However, the role each of these factors plays in arguing for or against androgen replacement remains controversial and more research is needed in many of these areas before the outstanding issues can be resolved. This article presents three cases involving patients who may require androgen supplementation. The cases describe (1) partial androgen deficiency syndrome, (2) testosterone deficiency in an anorchic man after bilateral orchiectomy for seminoma, and (3) a patient with sildenafil-refractory erectile dysfunction following treatment of localized prostate cancer with radiation therapy and androgen ablation. These cases illustrate some of the dilemmas and controversies surrounding androgen replacement that face the practicing urologist.

Entities:  

Year:  2003        PMID: 16985943      PMCID: PMC1502325     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  43 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men.

Authors:  S N Seidman; A B Araujo; S P Roose; J B McKinlay
Journal:  Biol Psychiatry       Date:  2001-09-01       Impact factor: 13.382

Review 3.  Erectile dysfunction and lipid disorders.

Authors:  M Schachter
Journal:  Curr Med Res Opin       Date:  2000       Impact factor: 2.580

4.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

5.  High-grade prostate cancer is associated with low serum testosterone levels.

Authors:  G Schatzl; S Madersbacher; T Thurridl; J Waldmüller; G Kramer; A Haitel; M Marberger
Journal:  Prostate       Date:  2001-04       Impact factor: 4.104

6.  Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy.

Authors:  S Slater; R T Oliver
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

7.  Effects of androgen deficiency and replacement on prostate zonal volumes.

Authors:  B Jin; A J Conway; D J Handelsman
Journal:  Clin Endocrinol (Oxf)       Date:  2001-04       Impact factor: 3.478

Review 8.  [PADAM from the urologic viewpoint].

Authors:  G Ludwig
Journal:  Urologe A       Date:  2000-09       Impact factor: 0.639

9.  Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.

Authors:  A T Guay; J B Perez; W A Fitaihi; M Vereb
Journal:  Endocr Pract       Date:  2000 Mar-Apr       Impact factor: 3.443

10.  Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience.

Authors:  F M Debruyne; W P Witjes
Journal:  Mol Urol       Date:  2000
View more
  1 in total

1.  Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of male Wistar albino rats.

Authors:  F C Onwuka; Kc Patrick-I Wuanyanwu; C K Nnodu; O Erhabor
Journal:  J Exp Pharmacol       Date:  2010-03-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.